Annual report [Section 13 and 15(d), not S-K Item 405]

INCOME TAXES

v3.26.1
INCOME TAXES
12 Months Ended
Dec. 31, 2025
INCOME TAXES  
INCOME TAXES

9.INCOME TAXES

As of December 31, 2025 and 2024, the net deferred tax assets have not been recognized in the accompanying consolidated financial statements. A valuation allowance is recognized to reduce the deferred tax asset as it is more likely than not that a tax benefit will not be realized.

The following are the significant components of the Company’s deferred taxes as of December 31:

  ​ ​ ​

2025

  ​ ​ ​

2024

Non-capital losses carried forward

$

34,810,450

$

24,850,000

Research and development expenditures

 

3,022,831

 

3,175,000

Investment tax credits

 

1,944,821

 

2,043,000

Tax value of technology rights and property and equipment in excess of accounting basis

 

160,999

 

193,000

Share issue costs

 

1,066,620

 

1,275,000

Non-deductible reserves

10,000

Restricted interest and financing expenses

 

 

337,000

Total deferred income tax assets

 

41,005,721

 

31,883,000

Valuation allowance

 

(41,005,721)

 

(31,883,000)

Net deferred income tax assets

$

$

As of December 31, 2025, the Company has available research and development expenditure credits for income tax purposes of approximately $11,407,000, which may be carried forward without expiration to reduce future taxable income.

As of December 31, 2025, the Company has non-capital income tax loss carry-forwards of approximately $131,360,190 available to reduce future income for income tax purposes. The income tax loss carry-forwards have expiry dates between the years 2026 and 2046.

As of December 31, 2025, the Company has approximately $2,553,000 of non-refundable investment tax credits available to offset future income taxes. The non-refundable investment tax credits have expiry dates between 2025 and 2035.

A reconciliation of the combined federal and provincial statutory income tax rate applied to the net (loss) income for the year to the income tax recovery as of December 31 is as follows:

Year Ended December 31, 

  ​ ​ ​

2025

  ​ ​ ​

Amount ($)

Percent (%)

Canadian federal statutory income tax rate

 

(5,960,583)

15.0

%  

Provincial taxes (Ontario)

11.5

Non-deductible expenses

127,981

(0.3)

Share issue costs recorded, net of equity

(372,011)

0.9

Change in valuation allowance

6,027,731

(26.8)

Return to provision adjustments

15,444

(0.1)

Other

161,438

(0.3)

Effective Tax Rate

The Company does not expect a significant change in the amount of unrecognized tax benefits over the next 12 months. However, any adjustments arising from certain ongoing examinations by tax authorities could alter the timing or amount of taxable income or deductions and these adjustments could differ from the amount accrued. The Company’s federal and provincial income tax returns files for all years remain subject to examination by the taxation authorities.